CNS Pharmaceuticals, Inc.

CNS Pharmaceuticals, Inc.

Biotechnology • Healthcare • Houston, TX, United States • CNSP (NCM)

CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, develops anti-cancer drug candidates for the treatment of brain and central nervous system (CNS) tumors. The company's drug candidates include TPI 287 and Berubicin, which are in Phase 2 clinical trial for the treatment of glioblastoma and other CNS malignancies. It has license agreement with Cortice Biosciences, Inc. The company was incorporated in 2017 and is headquartered in Houston, Texas.

800 946 9185 2100 West Loop South, Houston, TX 77027, United States

Stock Performance (90 Days)

Data through Dec 26, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

CNS Pharmaceuticals stock falls after CEO steps down - Investing.com
Investing.com • Dec 17
CNS Pharmaceuticals Announces New CEO Appointment - The Globe and Mail
The Globe and Mail • Dec 18
CNS Pharmaceuticals (NASDAQ: CNSP) has 3 SNO 2025 abstracts selected on Berubicin, TPI 287 - Stock Titan
Stock Titan • Nov 10
Aug Reactions: How CNS Pharmaceuticals Inc stock performs in rate cut cycles - 2025 Top Gainers & Capital Efficient Trading Techniques - moha.gov.vn
moha.gov.vn • Dec 27
CNS Pharmaceuticals Announces Pricing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules - Yahoo Finance
Yahoo Finance • May 13

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has CNS Pharmaceuticals, Inc. had layoffs?
No layoff events have been recorded for CNS Pharmaceuticals, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does CNS Pharmaceuticals, Inc. have?
CNS Pharmaceuticals, Inc. has approximately 4 employees.
What industry is CNS Pharmaceuticals, Inc. in?
CNS Pharmaceuticals, Inc. operates in the Biotechnology industry, within the Healthcare sector.
Is CNS Pharmaceuticals, Inc. a publicly traded company?
Yes, CNS Pharmaceuticals, Inc. is publicly traded under the ticker symbol CNSP on the NCM. The company has a market capitalization of approximately $0.00 billion.
Where is CNS Pharmaceuticals, Inc. headquartered?
CNS Pharmaceuticals, Inc. is headquartered in Houston, TX, United States at 2100 West Loop South, Houston, TX 77027, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.